CS-2015

N/A

Report date: 2025/07/18 11:49:36
First In Class

Base Information

Drug NameCS-2015
Drug Alias NameCS-2015CS2015
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionTumor necrosis factor ligand superfamily member 4 inhibitorsThymic stromal lymphopoietin inhibitors
TargetsTumor necrosis factor ligand superfamily member 4Thymic stromal lymphopoietin
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCstone Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesCstone Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A